fda glp-1 shortage Wegovy Pill Wins Approval as First Oral Treatment for Obesity and Weight Loss NCL urges FDA and consumers

Update on FDAs ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity

For example, butyrate producing bacteria and Akkermansia are decreased in type 2 diabetes mellitus patients 2

As a glucagon-like peptide-1 (GLP-1) receptor agonist, it replicates the actions of natural gut hormones released after eating

The researchers analyzed thousands of electronic medical records of older adults with both diabetes and cancer and found that those who were taking GLP-1s had lower all-cause mortality than did those who were taking another type of diabetes medication, dipeptidyl peptidase 4 inhibitors (DPP-4i)